Capecitabine
Published date: 2018-07-13 13:52:26
|
Name | Capecitabine | CAS# | 154361-50-9 |
|---|---|---|---|---|
| Price | $Inquiry/1kg | Purity | 99.9% | |
| Stocking Period |
Inquiry | Stock | In Stock |
| Detail
Product Information
Names [ Name ]: capecitabine [ Synonym ]: More Synonyms Chemical & Physical Properties [ Density ]: 1.5±0.1 g/cm3 [ Boiling Point ]: 517.6±60.0 °C at 760 mmHg [ Melting Point ]: 110-121°C [ Molecular Formula ]: C15H22FN3O6 [ Molecular Weight ]: 359.350 [ Flash Point ]: 266.8±32.9 °C [ Exact Mass ]: 359.149261 [ PSA ]: 122.91000 [ LogP ]: 0.97 [ Vapour Pressure ]: 0.0±3.1 mmHg at 25°C [ Index of Refraction ]: 1.600 MSDS Capecitabine MSDS(Chinese) Safety Information [ Symbol ]: GHS08 GHS08 [ Signal Word ]: Danger
[ Hazard Statements ]: H341-H350-H360FD [ Precautionary Statements ]: P201-P308 + P313 [ RIDADR ]: NONH for all modes of transport [ WGK Germany ]: 3 [ HS Code ]: 2934999090 Precursor & DownStream Precursor 7 Previous 1/2 Next pentyl (5-fluoro-1-((3aR,4R,6R,6aR)-6-methyl-2-oxidotetrahydrofuro[3,4-d][1,3,2]dioxathiol-4-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)carbamate Structure CAS#:1309454-52-1 pentyl (5-fluor... 5'-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine 2',3'-diacetate Structure CAS#:162204-20-8 5'-Deoxy-5-fluo... Amyl Chloroformate Structure CAS#:638-41-5 Amyl Chloroformate 5'-Deoxy-5-fluorocytidine Structure CAS#:66335-38-4 5'-Deoxy-5-fluo... DownStream 1 5'-Deoxy-5-fluorocytidine structure CAS#:66335-38-4 5'-Deoxy-5-fluo... Customs [ HS Code ]: 2934999090 [ Summary ]: 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% Articles84More Articles Risk factors for bowel dysfunction after sphincter-preserving rectal cancer surgery: a prospective study using the Memorial Sloan Kettering Cancer Center bowel function instrument. Dis. Colon Rectum 57(8) , 958-66, (2014) Until recently, no studies have prospectively evaluated bowel function after sphincter-preserving surgery for rectal cancer with the use of a validated bowel function scoring system.The aim of this st... Detail [A case of S-1/CDDP-resistant recurrent gastric cancer responsive to capecitabine/CDDP]. Gan To Kagaku Ryoho. 41(5) , 649-51, (2014) We present a case of recurrent gastric cancer in which stable disease status was achieved for four months due to treatment with capecitabine/cisplatin (CDDP)after the failure of multiple anticancer dr... Detail Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis. J. Clin. Oncol. 32(10) , 1031-9, (2014) Fluourouracil (FU) is a mainstay of chemotherapy, although toxicities are common. Genetic biomarkers have been used to predict these adverse events, but their utility is uncertain.We tested candidate ... Detail Synonyms 2(1H)-Pyrimidinone, 1-(5-deoxypentofuranosyl)-5-fluoro-4-[[(pentyloxy)carbonyl]amino]- 1-(5-Deoxypentofuranosyl)-5-fluoro-4-{[(pentyloxy)carbonyl]amino}-2(1H)-pyrimidinone 5'-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine Capecitabine 5'-Deoxy-5-fluoro-N4-[(pentyloxy)carbonyl]cytidine Capecytabine Ro 09-1978 Captabin MFCD00930626 XELODA RO-9-1978 Cpecitabine Capecitibine 1-(5-deoxypentofuranosyl)-5-fluoro-4-{[(pentyloxy)carbonyl]amino}pyrimidin-2(1h)-one Ro 09-1978/000 More
|